University of Connecticut Schools of Nursing and Medicine, Storrs Mansfield, Connecticut.
Mayo Clinic, Rochester, Minnesota.
J Clin Sleep Med. 2023 Jun 1;19(6):1073-1081. doi: 10.5664/jcsm.10498.
Cognitive impairment and insomnia are common in chronic heart failure (HF). We examined the effects of cognitive behavioral therapy for insomnia (CBT-I) and the extent to which demographic, clinical, symptom, and functional characteristics predicted cognition among people with chronic HF and insomnia who participated in a randomized controlled trial of CBT-I.
Participants with HF were randomized to group-based CBT-I or an attention control (HF self-management education). Outcomes were measured over 1 year. We measured psychomotor vigilance and self-reported cognitive ability (PROMIS Cognitive Abilities Scale), clinical and demographic characteristics, history of sleep apnea, fatigue, pain, insomnia (Insomnia Severity Index), sleepiness (Epworth Sleepiness Scale), Six Minute Walk, EuroQoL Quality of Life, and wrist actigraphy (sleep characteristics and rest-activity rhythms). We used cosinor analysis to compute rest-activity rhythms and general linear models and general estimating equations to test the effects of predictors over 1 year.
The sample included 175 participants (mean age = 63 SD = 12.9 Years; 43% women). There was a statistically significant group-time effect on self-reported cognitive function and increases in the proportion of participants, with < 3 psychomotor vigilance lapses in the CBT-I group. Controlling for group-time effects and baseline cognition, decreased sleepiness, improved rest-activity rhythms, and 6-minute walk distance predicted a composite measure of cognition (psychomotor vigilance lapses and self-reported cognition).
CBT-I may improve cognition in adults with chronic HF. A future fully powered randomized controlled trial is needed to confirm the extent to which CBT-I improves multiple dimensions of cognition.
Registry: ClinicalTrials.gov; Name: Cognitive Behavioral Therapy for Insomnia: A Self-Management Strategy for Chronic Illness in Heart Failure; URL: https://clinicaltrials.gov/ct2/show/NCT02660385; Identifier: NCT02660385.
Redeker NS, Conley S, O'Connell M, Geer JH, Yaggi H, Jeon S. Sleep-related predictors of cognition among adults with chronic insomnia and heart failure enrolled in a randomized controlled trial of cognitive behavioral therapy for insomnia. . 2023;19(6):1073-1081.
认知障碍和失眠在慢性心力衰竭(HF)中很常见。我们研究了认知行为治疗失眠症(CBT-I)的效果,以及人口统计学、临床、症状和功能特征在参加 CBT-I 随机对照试验的慢性 HF 和失眠症患者中的认知程度。
将 HF 患者随机分为基于小组的 CBT-I 或注意力对照组(HF 自我管理教育)。结果在 1 年内进行测量。我们测量了精神运动警觉性和自我报告的认知能力(PROMIS 认知能力量表)、临床和人口统计学特征、睡眠呼吸暂停史、疲劳、疼痛、失眠(失眠严重程度指数)、嗜睡(Epworth 嗜睡量表)、六分钟步行、欧洲五维健康量表和手腕活动记录仪(睡眠特征和休息-活动节律)。我们使用余弦分析计算休息-活动节律,使用一般线性模型和一般估计方程在 1 年内测试预测因子的效果。
样本包括 175 名参与者(平均年龄=63 岁,标准差=12.9 岁;43%为女性)。CBT-I 组的自我报告认知功能和参与者比例有统计学意义的组间时间效应,且精神运动警觉性缺失<3 次。控制组间时间效应和基线认知后,嗜睡程度降低、休息-活动节律改善和 6 分钟步行距离可预测认知的综合测量值(精神运动警觉性缺失和自我报告认知)。
CBT-I 可能改善慢性 HF 成人的认知能力。需要进行一项未来的完全随机对照试验,以确认 CBT-I 在多大程度上改善了认知的多个维度。
注册:ClinicalTrials.gov;名称:失眠症的认知行为治疗:慢性疾病的自我管理策略在心力衰竭中;网址:https://clinicaltrials.gov/ct2/show/NCT02660385;标识符:NCT02660385。
Redeker NS, Conley S, O'Connell M, Geer JH, Yaggi H, Jeon S. 睡眠相关因素预测参加认知行为治疗失眠症随机对照试验的慢性失眠症和心力衰竭成人的认知。. 2023;19(6):1073-1081.